Core Viewpoint - The transaction involving Lionhead Technology Development Co., Ltd. is confirmed to have no related parties that are prohibited from participating in major asset restructuring according to regulatory guidelines [1][2]. Group 1: Transaction Details - Lionhead Technology Development Co., Ltd. plans to acquire 97.4399% of Hangzhou Lipe Technology Co., Ltd. shares from 14 counterparties through a combination of issuing shares and cash payments [1]. - The company will also issue shares to Chongqing Yiyuan Enterprise Management Co., Ltd. and Chongqing Yicheng Enterprise Management Co., Ltd. to raise supporting funds for this transaction [1]. Group 2: Regulatory Compliance - The independent financial advisor, Dongfang Securities Co., Ltd., conducted a review and found that none of the transaction-related parties are under investigation for insider trading related to this transaction [1]. - There have been no administrative penalties or criminal liabilities imposed by the China Securities Regulatory Commission on the related parties in the last 36 months concerning major asset restructuring [1].

东方证券股份有限公司 关于狮头科技发展股份有限公司本次交易方案调整不构成 重组方案重大调整的核查意见 狮头科技发展股份有限公司（以下简称"公司"、"上市公司"）拟通过 发行股份及支付现金方式，购买王旭龙琦、邓浩瑜等 14 名交易对方合计持有的 杭州利珀科技股份有限公司（以下简称"利珀科技"）97.4399%股份，并向重 庆益元企业管理有限公司、重庆益诚企业管理有限公司发行股份募集配套资金 （以下简称"本次交易"）。 东方证券股份有限公司（以下简称"独立财务顾问"）接受上市公司委托， 担任本次交易的独立财务顾问，对本次交易方案调整事项进行核查，并出具如 下核查意见： 一、本次交易方案调整情况 （一）调整前的交易方案 根据公司于 2025 年 3 月 6 日召开的第九届董事会第十九次会议审议通过的 《关于 <狮头科技发展股份有限公司发行股份及支付现金购买资产并募集配套资> 金暨关联交易预案>及其摘要的议案》，本次交易的初始方案具体如下： 公司拟通过发行股份及支付现金方式，向王旭龙琦、邓浩瑜、李言衡、杭 州利珀投资管理合伙企业（有限合伙）、深圳芯瑞创业投资合伙企业（有限合 伙）、深圳众微首润智能装备创业投资合伙企业 ...

Core Viewpoint - The transaction involving Lionhead Technology Development Co., Ltd. aims to acquire a 97.4399% stake in Hangzhou Lipo Technology Co., Ltd. through a combination of share issuance and cash payment, with measures in place to mitigate the dilution of immediate returns for shareholders [1][4]. Summary by Sections Impact on Earnings Per Share - Following the transaction, the basic and diluted earnings per share (EPS) are projected to increase from 0.00 yuan/share to 0.01 yuan/share, reflecting an increase of 88.95% [2][4]. Measures to Mitigate Dilution Risk - The company plans to enhance its governance structure and risk management capabilities to improve operational efficiency post-transaction [3][4]. - A commitment to optimize profit distribution policies and investment return mechanisms will be made to protect shareholder interests [3][4]. - The company has established performance commitments and corresponding compensation arrangements with the transaction parties to further mitigate the risk of immediate return dilution [3][4]. Commitments from Major Stakeholders - The controlling shareholders and management have made commitments to not interfere with the company's operations or infringe on its interests, ensuring adherence to new regulatory requirements as they arise [4]. - The board and senior management have pledged to avoid unfair benefit transfers and to align their performance with the execution of return compensation measures [4]. Independent Financial Advisor's Opinion - The independent financial advisor has confirmed that the transaction will enhance the company's earnings per share and that the proposed measures to prevent dilution are in compliance with relevant regulations aimed at protecting minority investors [4].

Core Viewpoint - The transaction involves the acquisition of 97.4399% of shares in Lipo Technology by Lionhead Technology through a combination of issuing shares and cash payment, with the independent financial advisor confirming the compliance with regulatory guidelines [1][2]. Industry and Company Summary - The main business of Lipo Technology focuses on the research, development, production, and sales of machine vision-related technology products, classified under "C35 Specialized Equipment Manufacturing" in the national economic industry classification [1]. - The independent financial advisor concluded that the industry involved in this transaction does not fall under the categories specified by the China Securities Regulatory Commission (CSRC) for urgent integration and transformation [2]. - The transaction type does not represent a merger within the same industry or upstream/downstream acquisition, as Lionhead Technology primarily operates in e-commerce services, while Lipo Technology serves various emerging manufacturing sectors [2][3]. - The transaction does not constitute a restructuring listing as there has been no change in the controlling shareholder or actual controller within the last thirty-six months [2][3]. - The transaction involves the issuance of shares as part of the acquisition process [3]. - As of the date of the independent financial advisor's opinion, Lionhead Technology is not under investigation by the CSRC [4].

Core Viewpoint - The independent financial advisor, Dongfang Securities, conducted a review of the asset purchase and sale activities of Lionhead Technology Development Co., Ltd. in the 12 months prior to a significant transaction involving the acquisition of a 97.4399% stake in Hangzhou Lipe Technology Co., Ltd. [1] Group 1: Transaction Overview - Lionhead Technology plans to acquire a majority stake in Hangzhou Lipe Technology through a combination of issuing shares and cash payments to 14 counterparties [1] - The transaction will also involve raising supporting funds through share issuance to Chongqing Yiyuan Enterprise Management Co., Ltd. and Chongqing Yicheng Enterprise Management Co., Ltd. [1] Group 2: Regulatory Compliance - The review was conducted in accordance with the "Measures for the Administration of Major Asset Restructuring of Listed Companies," which stipulates that continuous purchases or sales of the same or related assets within 12 months must be cumulatively calculated [1] - The China Securities Regulatory Commission (CSRC) has specific regulations regarding the cumulative period and scope of major asset restructuring [1] Group 3: Previous Transactions - In the 12 months prior to the current transaction, Lionhead Technology did not engage in any other asset purchase or sale activities, aside from the independent transactions with Chongqing Zhiwei Technology Co., Ltd. and Chongqing Chain Pet Technology Co., Ltd. [2] - The previous transactions are deemed independent and do not fall under the same or similar business scope, thus not requiring cumulative calculation [2]

Group 1 - The company intends to acquire 97.4399% of Hangzhou Lipe Technology Co., Ltd. through a combination of issuing shares and cash payments to 14 counterparties [1] - The independent financial advisor, Dongfang Securities Co., Ltd., confirmed that it did not hire any third parties for this transaction, ensuring compliance with relevant regulations [1][2] - The company has engaged several legal and financial advisors for the transaction, including Dongfang Securities as the independent financial advisor, Guohao Law Firm as the legal advisor, and Tianjian Accounting Firm for auditing [2] Group 2 - The independent financial advisor's review concluded that there were no undisclosed third-party hires by the company, aligning with the regulatory requirements [2] - The hiring of the mentioned intermediary institutions was deemed legal and compliant with the regulations regarding third-party engagements in investment banking [2]

一、内幕信息知情人登记制度的制定情况 东方证券股份有限公司 关于狮头科技发展股份有限公司内幕信息知情人登记制度 的制定和执行情况的核查意见 狮头科技发展股份有限公司（以下简称"公司"、"上市公司"）拟通过 发行股份及支付现金方式，购买王旭龙琦、邓浩瑜等 14 名交易对方合计持有的 杭州利珀科技股份有限公司 97.4399%股份，并向重庆益元企业管理有限公司、 重庆益诚企业管理有限公司发行股份募集配套资金（以下简称"本次交易"）。 东方证券股份有限公司（以下简称"独立财务顾问"）接受上市公司委托， 担任本次交易的独立财务顾问，现对上市公司内幕信息知情人登记制度的制定 和执行情况进行核查，核查意见如下： 上市公司已根据《中华人民共和国证券法》《上市公司信息披露管理办法》 《上海证券交易所股票上市规则》《上市公司监管指引第 5 号——上市公司内 幕信息知情人登记管理制度》等有关法律、法规、规范性文件制定了《内幕信 息及知情人管理制度》，明确内幕信息及内幕信息知情人的范围、内幕信息知 情人的登记备案、内幕信息知情人的保密责任及义务及责任追究机制等内容。 二、内幕信息知情人登记制度的执行情况 （一）上市公司在本次交易中 ...

证券代码：600539 证券简称：狮头股份 公告编号：临 2025-051 狮头科技发展股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 狮头科技发展股份有限公司（以下简称"公司"、"上市公司"）拟通过发 行股份及支付现金方式，购买王旭龙琦、邓浩瑜等 14 名交易对方合计持有的杭 州利珀科技股份有限公司（以下简称"利珀科技"、"标的公司"）97.4399% 股份，并向重庆益元企业管理有限公司、重庆益诚企业管理有限公司发行股份募 集配套资金（以下简称"本次交易"）。 公司董事会就本次交易方案进行了认真、审慎分析，现将本次交易涉及的公 司股东权益变动情况公告如下： 一、本次权益变动基本情况 公司拟通过发行股份及支付现金的方式购买利珀科技 97.4399%股份并募集 本次交易前后，上市公司的股权结构变化情况如下： | | 本次交易前 | 本次交易后 | 本次交易后 | | --- | --- | --- | --- | | | | （不含配套融资） | （含配套融资） | | 股东名称 | | | | | | 持股数 ...

人民财讯8月6日电，狮头股份（600539）8月6日晚间公告，公司拟通过发行股份及支付现金的方式取得 利珀科技97.4399%股份，并募集配套资金，交易价格(不含募集配套资金金额)为6.62亿元。利珀科技主 要从事机器视觉相关技术产品的研发、生产与销售业务，可为下游众多新兴制造行业客户提供通用视觉 算法软件和视觉解决方案。通过本次交易，公司将实现战略转型，切入到机器视觉领域，打造第二增长 曲线。 ...

狮头科技发展股份有限公司 简式权益变动报告书 上市公司名称：狮头科技发展股份有限公司 股票上市地点：上海证券交易所 股票简称：狮头股份 股票代码：600539.SH 信息披露义务人一：上海远涪企业管理有限公司 住所：上海市闵行区沪青平公路 277 号 5 楼 F104 室 通讯地址：上海市闵行区沪青平公路 277 号 5 楼 F104 室 信息披露义务人二：上海桦悦企业管理有限公司 住所：上海市长宁区宣化路 3 号 2 层 2736 室 通讯地址：上海市长宁区宣化路 3 号 2 层 2736 室 信息披露义务人三：重庆益元企业管理有限公司 住所：重庆市渝中区石油路街道经纬大道 789 号 10-2#F037# 通讯地址：重庆市渝中区石油路街道经纬大道 789 号 10-2#F037# 信息披露义务人四：重庆益诚企业管理有限公司 住所：重庆市渝中区石油路街道经纬大道 789 号 10-2#F038# 通讯地址：重庆市渝中区石油路街道经纬大道 789 号 10-2#F038# 权益变动性质：增加（重庆益元、重庆益诚认购上市公司增发的新股）、减少 （上海远涪、上海桦悦因上市公司增发新股导致持股比例被动稀释） 签署日 ...